Silver Nanoparticles for Wound Healing: Mechanisms and Therapeutic Insights
Biomedical Materials & Devices · 16.11.2026
DOI: 10.1007/s44174-026-00801-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Materials & Devices, online erschienen am 16.11.2026. Verfasst von Dhvani Rafaliya und 5 weiteren Autor:innen. Die Arbeit nennt 108 Literaturangaben.
Themen: Wundversorgung
Abstract (Originalsprache)
Silver nanoparticles (AgNPs) have attracted considerable interest in wound management, but their therapeutic performance remains dependent on nanoparticle characteristics, dose, synthesis route, silver-ion release, and formulation. This review critically evaluates AgNPs synthesis, physicochemical properties, biological mechanisms, wound-dressing platforms, safety, clinical evidence, and translational challenges, with particular emphasis on factors responsible for variability in therapeutic outcomes. A structured literature search was conducted across major scientific databases using combinations of keywords related to silver nanoparticles, wound healing, antimicrobial activity, inflammation, nanocomposite dressings, toxicity, and clinical applications, with emphasis on recent and relevant foundational studies. The reviewed evidence demonstrates substantial preclinical potential but heterogeneous outcomes. Reported AgNPs hydrogel formulations achieved 85.52–94.54% wound healing by day 10 compared with 60.12% in controls, while an AgNPs-containing hydrogel produced antibacterial inhibition zones of 24–27 mm and reduced wound area to 41.3% after 7 days in a reported animal model. AgNPs have been incorporated into hydrogels, electrospun nanofibers, films, foams, scaffolds, and stimuli-responsive systems to facilitate localized delivery and antimicrobial activity. However, dose-dependent cytotoxicity, silver-ion exposure, formulation variability, manufacturing reproducibility, uncertain long-term safety, and limited high-quality clinical evidence remain important barriers to translation. Overall, AgNPs represent a formulation- and dose-dependent platform with potential for wound management. Standardized characterization, clinically relevant models, comparative clinical studies, and long-term safety evaluation are required to define their therapeutic value and support clinical translation. Graphical Abstract
Zitieren
APA
Rafaliya, D., Dineshbhai, T. K., Singh, A., Maheshwari, S., Lalan, M., & Chakraborthy, G. S. (2026). Silver Nanoparticles for Wound Healing: Mechanisms and Therapeutic Insights. Biomedical Materials & Devices. https://doi.org/10.1007/s44174-026-00801-2
Vancouver
Rafaliya D, Dineshbhai TK, Singh A, Maheshwari S, Lalan M, Chakraborthy GS. Silver Nanoparticles for Wound Healing: Mechanisms and Therapeutic Insights. Biomedical Materials & Devices. 2026. doi:10.1007/s44174-026-00801-2
BibTeX
@article{Rafaliya2026,
author = {Rafaliya, Dhvani and Dineshbhai, Thumbar Kishan and Singh, Aditya and Maheshwari, Shubhrat and Lalan, Manisha and Chakraborthy, Guno Sindhu},
title = {Silver Nanoparticles for Wound Healing: Mechanisms and Therapeutic Insights},
journal = {Biomedical Materials & Devices},
year = {2026},
doi = {10.1007/s44174-026-00801-2}
}
EUVIMED